Blog
Flow Matters: The Power of Flow Cytometry in MRD Detection in Oncology
Insight to Impact: Driving Innovation Across Therapeutic Areas
Expert perspectives on flow cytometry, oncology, biomarkers, and the evolving landscape of global drug development.
Welcome to Insight to Impact
Knowledge accelerates scientific progress.
Here, we bring together thought leadership, technical guidance, and emerging trends to support researchers, sponsors, and healthcare innovators worldwide to bring therapeutics to patients – faster.
Featured blogs
Flow Matters: Illuminating Immune Responses in Virology and Vaccine Testing
In this edition of the Flow Matters blog, we’re diving into how flow cytometry is transforming virology and vaccine research and how new technological advances are giving researchers an unprecedented view of the immune system in action.
How Custom Assays and Biobanking Drive Better Clinical Outcomes
One of the most significant challenges facing biopharmaceutical and biotechnology companies is translating complex science into meaningful clinical outcomes. Kirsty Maclean, Global Head of R&D, talks about how our integrated framework helps accelerate decision-making.
Insights from IO & Biomarker Summit 2026
The IO & Biomarker Summit, held in London, UK, from 16-17 March, brought together a diverse group of stakeholders across the oncology landscape. Explore our key scientific insights, along with highlights from our presentation.
Our latest blogs
23 assets showing
No matches found
No matches found
No matches found
Blog
Combining Flow Cytometry, IHC & NGS in Immuno-oncology: Essential Trio for Biomarker Success
Blog
Flow Matters: Selecting the Right Reagents and Instruments for Flow Cytometry
Blog
Flow Matters: Understanding Autoimmunity: How Flow Cytometry Advances Trials
Blog
Flow Matters: Principles of Clinical Flow Assay Design
Blog
Flow Matters: The Role of Flow Cytometry in CAR-T Therapy Clinical Trials
Blog
Flow Matters: How to Go with the Flow (Cytometry) In Clinical Trials
